# Abiomed plans €100M investment to triple production in Aachen by 2027

Abiomed plans to invest nearly €100 million by 2027 to triple production of Impella heart pumps at its Aachen site. The expansion includes a 7,700 m² building, a new parking garage, and a logistics center in Würselen, doubling the workforce to 600.

- Type: Expansion
- Announced: 2023-12-13
- Where: Aachen, Germany
- Value: $109.0M (100.0M EUR)
- Jobs: 300
- Starts operating: 2027
- Status: announced
- Capacity: triple production of 1000 Impella pumps per week
- Products: Impella heart pumps
- Sectors: [Medical Devices](https://endata.com/sectors/medical-devices.md)

## Companies

- [Abiomed](https://endata.com/companies/9846.md)

## Sources

- [medlife-ev.de](https://medlife-ev.de/en/abiomed-100m/), 2023-12-13: "Um die Produktion zu verdreifachen, sind bis 2027 Investitionen von fast 100 Millionen Euro geplant."

---
Data from Endata (https://endata.com/). Announcements are summarized from public sources and may be incomplete; check the linked originals.